Intended Use

LEPZI ® Quanti cTnI Test is a fluorescence immunoassay for the quantitative determination of cardiac Troponin I (cTnI) in EDTA anticoagulated whole blood or plasma samples.

The test is intended for use as an aid in the diagnosis of myocardial infarction (injury)in conjunction with other diagnostic and clinical information.

Clinical Application

The preferred marker for the diagnosis of myocardial infarction（MI）

The "Gold Standard" for AMI diagnosis

Prognostic assessment and risk stratification of ACS

Evaluation of myocardial ischemia injury area

Measure the extent of myocardial damage caused by heart surgery

Improving patient management

Specification

Test Analyte：cTnI

Specimen：EDTA anticoagulated human whole blood or plasma samples

Reaction Time：15 minutes in Single Cartridge Mode, 55 seconds in Multi Cartridge Mode

Storage：2~8°C

Registration：CE, NMPA

Advantages 

Fully Enclosed Test Area - Stable and reliable reaction

Ultrasonic Welded Seal - Tightly sealed and high precision

Easy to Use - No sample dilution and preparation